Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Revision of Deep Brain Stimulator in Patients With Parkinson's Disease

Revision of Deep Brain Stimulator in Patients With Parkinson's Disease: A Comparison of Perioperative Characteristics of Regional and General Anesthesia

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Parkinson's disease is a chronic and progressive neurodegenerative disease that affects the central nervous system, particularly impairing movement control. It is associated with the loss of dopamine-producing cells in the brain and typically occurs in middle age and beyond. Deep brain stimulation (DBS) is considered when symptoms of Parkinson's disease, such as tremors, slowed movements, and muscle rigidity, are not adequately controlled with medications. Selected patients with severe symptoms that do not respond to medical treatment are generally considered for this treatment. Battery revision surgeries can be performed under general anesthesia or regional anesthesia. Patients undergoing general anesthesia should be cautious about the potential complications of general anesthesia, while those undergoing regional anesthesia should be cautious about the local anesthetic systemic toxicity. Because each method has its own advantages, the choice of anesthesia may vary. This study aimed to compare postoperative analgesic efficacy and patient satisfaction in patients who underwent surgery under general anesthesia or sedation-assisted battery replacement under regional anesthesia. Both anesthesia methods are routinely used in Parkinson's disease patients undergoing battery replacement.

Who May Be Eligible (Plain English)

Who May Qualify: - Those aged 40-85 - Those with an ASA score of I-II-III - Those with a body mass index (BMI) between 18-30 Who Should NOT Join This Trial: - Those under 40 and over 85 - Those with an ASA score of IV or higher - Those with a BMI of under 18 and over 30 Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Those aged 40-85 * Those with an ASA score of I-II-III * Those with a body mass index (BMI) between 18-30 Exclusion Criteria: * Those under 40 and over 85 * Those with an ASA score of IV or higher * Those with a BMI of under 18 and over 30

Treatments Being Tested

PROCEDURE

Patients who underwent surgery under general anesthesia

Patients undergoing surgery under general anesthesia will undergo general anesthesia induction. During the skin closure, patients received 50 mg of dexketoprofen. Additionally, a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered intravenously for multimodal analgesia.

PROCEDURE

Patients who underwent surgery under regional anesthesia

25 cc (15 cc 0.5% bupivacaine + 5 cc 2% lidocaine + 5 cc isotonic) local anesthetic solution is prepared. 10 cc of the medication is administered into the interpectoral plane, and 15 cc into the pectoserratus plane. During the skin closure, patients received 50 mg of dexketoprofen. Additionally, a paracetamol dose of 1 g every 8 hours and a dexketoprofen dose of 50 mg twice daily were administered intravenously for multimodal analgesia.

Locations (1)

Ankara Etlik City Hospital
Ankara, Yenimahalle\Ankara, Turkey (Türkiye)